Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Therapeutics Development

Background:

• RNA interference (RNAi) therapeutics, utilizing short interfering RNAs (siRNAs), face delivery challenges like nuclease degradation and immunogenicity.
• Viral vectors show high transfection but pose safety and cost concerns.
• Non-viral cationic vectors (NVCVs) are explored as safer, more effective alternatives for siRNA delivery.

Purpose of the Study:

• To review the historical development and advancements in Non-viral Cationic Vectors (NVCVs) for siRNA delivery.
• To discuss functionalized NVCVs designed for enhanced stability, targeted cancer cell response, and receptor-specific targeting.
• To explore Multifunctional NVCVs (MNVCVs) that integrate multiple components for synergistic improvements in siRNA delivery efficacy.

Main Methods:

• Review of existing literature on NVCVs and their applications in RNAi.
• Analysis of functionalization strategies for NVCVs, including linkers and targeting ligands.
• Discussion of MNVCV designs and their components for enhanced siRNA delivery.

Main Results:

• NVCVs present a viable alternative to viral vectors for siRNA delivery.
• Functionalized NVCVs demonstrate improved stability and targeted delivery to cancer cells.
• MNVCVs show potential for synergistic effects, enhancing overall siRNA delivery efficiency.

Conclusions:

• NVCVs, particularly functionalized and multifunctional designs, are crucial for overcoming siRNA delivery barriers.
• Targeted and responsive NVCVs hold significant promise for advancing RNAi-based cancer therapeutics.
• Further development of NVCVs is essential for realizing the full therapeutic potential of RNAi.